Humira for Crohn's Disease
Available by prescription only, Humira® (adalimumab) is a medicine used to treat several inflammatory conditions, including Crohn's disease. This disease is a type of "inflammatory bowel disease," or "IBD."
Although it is not a cure for Crohn's disease, Humira is approved to reduce the signs and symptoms of this disease and to maintain remission of Crohn's disease.
As part of a class of drugs known as tumor necrosis factor inhibitors, or TNF inhibitors for short, Humira works by blocking the activity of tumor necrosis factor-alpha (TNF-alpha). TNF-alpha is a naturally occurring chemical in the body that is involved in inflammation and other immune system functions.
People with Crohn's disease often have higher levels of TNF-alpha. These high levels of TNF-alpha can cause inflammation and lead to problems. By blocking TNF-alpha, Humira helps to relieve the symptoms of these conditions and, in some cases, prevents future damage from occurring.
(For more information on using this medication for Crohn's disease, click Humira Uses. This article also discusses how Humira works for treating other inflammatory conditions, as well as possible off-label uses of the drug.)